US FDA approves Enspryng from Genentech for neuromyelitis optica spectrum disorder
In two randomised controlled Phase III clinical trials, SAkuraStar and SAkuraSky studies, Enspryng demonstrated robust and…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.